首页> 外文期刊>The journal of gene medicine >Gene conjugation of molecular adjuvant C3d(3) to hCG beta increased the anti-hCG beta Th2 and humoral immune response in DNA immunization
【24h】

Gene conjugation of molecular adjuvant C3d(3) to hCG beta increased the anti-hCG beta Th2 and humoral immune response in DNA immunization

机译:分子佐剂C3d(3)与hCG beta的基因缀合增加了DNA免疫中的抗hCG beta Th2和体液免疫反应

获取原文
获取原文并翻译 | 示例
           

摘要

Human chorionic gonadotropin (hCG) has been used as an anti-fertility vaccine and as a target for cancer immunotherapy. We have explored the use of three copies of C3d in DNA vaccine as molecular adjuvant to improve the immunogenicity of this hormone in previous work and found that the immune response induced by pcDNA3-hCG beta-C3d(3) has been enhanced 243-fold compared with pcDNA3-hCG beta following DNA immunization in BALB/c mice. In the present study, a new functionally active DNA vaccine of hCG beta-C3d(3) chimera based on pCMV4 vector has been described. We compared the expression efficiency of pCMV4 and pcDNA3 eukaryotic vectors for hCG beta and hCG beta-C3d(3) fusion protein and the immune response of mice immunized with pcDNA3-hCG beta, pCMV4-hCG beta, pcDNA3-hCG beta-C3d(3) and pCMV4-hCG beta-C3d(3), respectively, at 25, 50 and 100 pmol dose, and further analyzed the levels of Th1 and Th2 cytokines produced by spleen lymphocytes of the immunized mice upon hCG restimulation in vitro. It was found that pCMV4 vector achieved 1.3-1.5-fold higher protein expression and raised 1.1-1.2 (primary) and 1.2-1.3 (booster) logs higher titer of anti-hCG beta IgG than pcDNA3. Mice vaccinated with 50 pmol of hCG beta-C3d(3)-DNAs elicited the highest titer of hCG beta-specific antibody among the serial doses and the immune response induced by pCMV4-hCG beta-C3d(3) were, respectively, 1.3, 1.3 and 1.2 logs higher than that of pcDNA3-hCG beta-C3d(3) and 2.2, 2.9 and 2.4 logs higher than that of pCMV4-hCG beta at week 2 following the booster immunization. Moreover, we observed that the production of IL-4 and IL-10 increased in mice vaccinated with hCG beta-C3d(3)-DNAs and the ratio of IL-4/IFN-(gamma) showed a Th2 bias of immune response in the mice immunized with hCG beta-C3d(3)-DNAs. These findings indicated that gene fusion of C3d(3) to hCG beta, as a means of harnessing the adjuvant potential of the innate immune system, may improve the antigen-specific Th2 humoral immune response of the hCG DNA vaccine and the pCMV4 vector is a more ideal eukaryotic vector for DNA vaccine than pcDNA3. Copyright (c) 2006 John Wiley & Sons, Ltd.
机译:人绒毛膜促性腺激素(hCG)已被用作抗生育疫苗和癌症免疫疗法的靶标。我们已经研究了在DNA疫苗中使用三份C3d作为分子佐剂来改善这种激素的免疫原性的方法,并发现pcDNA3-hCG beta-C3d(3)诱导的免疫应答与以前相比提高了243倍在BALB / c小鼠中进行DNA免疫后,用pcDNA3-hCG beta免疫接种。在本研究中,已经描述了一种基于pCMV4载体的hCG beta-C3d(3)嵌合体的新功能活性DNA疫苗。我们比较了pCMV4和pcDNA3真核载体对hCG beta和hCG beta-C3d(3)融合蛋白的表达效率以及用pcDNA3-hCG beta,pCMV4-hCG beta,pcDNA3-hCG beta-C3d(3)免疫的小鼠的免疫应答)和pCMV4-hCG beta-C3d(3)分别以25、50和100 pmol的剂量给药,并进一步分析了hCG体外再刺激后免疫小鼠脾淋巴细胞产生的Th1和Th2细胞因子的水平。已经发现,pCMV4载体的蛋白表达提高了1.3-1.5倍,抗hCGβIgG的滴度比pcDNA3提高了1.1-1.2(主要)和1.2-1.3(增强子)。在连续剂量中,接种50 pmol hCG beta-C3d(3)-DNA的小鼠引起的hCG beta特异性抗体最高滴度,并且pCMV4-hCG beta-C3d(3)诱导的免疫应答分别为1.3,加强免疫后第2周,比pcDNA3-hCG beta-C3d(3)高1.3和1.2个对数,比pCMV4-hCG beta高2.2、2.9和2.4。此外,我们观察到在接种hCG beta-C3d(3)-DNA的小鼠中IL-4和IL-10的产生增加,并且IL-4 /IFN-γ的比例在免疫反应中表现出Th2偏倚。用hCG beta-C3d(3)-DNA免疫的小鼠。这些发现表明C3d(3)与hCG beta的基因融合,作为利用先天免疫系统佐剂的一种手段,可以改善hCG DNA疫苗的抗原特异性Th2体液免疫反应,而pCMV4载体是一种DNA疫苗比pcDNA3更理想的真核载体。版权所有(c)2006 John Wiley&Sons,Ltd.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号